Augusto C. Ochoa
18Patents
8h-index
26Co-inventors
72Inventor score
Filing activity: Mar 21, 1988 → Sep 9, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5443983A | Method of culturing lymphocytes and method of treatment using such lymphocytes | Chemistry; Metallurgy | 67 | Expired |
| US5658744A | Methods of identifying patients having an altered immune status | Emerging Cross-Sectional Technologies | 27 | Expired |
| US5409698A | Liposome immunoadjuvants containing IL-2 | Emerging Cross-Sectional Technologies | 26 | Expired |
| US5965366A | Methods of identifying patients having an altered immune status | Emerging Cross-Sectional Technologies | 20 | Expired |
| US5556763A | Evaluation and treatment of patients with progressive immunosuppression | Human Necessities | 19 | Expired |
| US5296353A | Evaluation and treatment of patients with progessive immunosuppression | Human Necessities | 18 | Expired |
| US5773006A | Lipsome containing IL-2 | Emerging Cross-Sectional Technologies | 9 | Expired |
| US5725855A | Method of treating tumors with CD8.sup.+ -depleted or CD4.sup.+ T cell subpopulations | Chemistry; Metallurgy | 8 | Expired |
| US6312718A | Vaccine for B-cell malignancies | Human Necessities | 7 | Expired |
| US5650152A | Liposome immunoadjuvants containing IL-2 | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5316763A | Short-term anti-CD3 stimulation of lymphocytes to increase their in vivo acitivity | Chemistry; Metallurgy | 7 | Expired |
| US5583002A | Evaluation and treatment of patients with progressive immunosuppression | Human Necessities | 2 | Expired |
| US11723906B2 | PARP-1 and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US9752145B2 | Compositions and methods for reducing C/EBP homologous protein activity in myeloid-derived suppressor cells | Chemistry; Metallurgy | 1 | Active |
| US5889143A | Evaluation and treatment of patients with progressive immunosuppression | Human Necessities | 1 | Expired |
| US5641677A | Method of enhancing the immunotherapeutic activity of immune cells by depletion of CD8.sup.+ T cells | Chemistry; Metallurgy | 0 | Expired |
| US9011845B2 | Methods for treatment of inflammatory and infectious viral diseases | Chemistry; Metallurgy | 0 | Active |
| US8877183B2 | Methods for treatment of ocular diseases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.